PMID- 36305821 OWN - NLM STAT- MEDLINE DCOM- 20221109 LR - 20221110 IS - 1362-4962 (Electronic) IS - 0305-1048 (Print) IS - 0305-1048 (Linking) VI - 50 IP - 19 DP - 2022 Oct 28 TI - Vitamin C enhances NF-kappaB-driven epigenomic reprogramming and boosts the immunogenic properties of dendritic cells. PG - 10981-10994 LID - 10.1093/nar/gkac941 [doi] AB - Dendritic cells (DCs), the most potent antigen-presenting cells, are necessary for effective activation of naive T cells. DCs' immunological properties are modulated in response to various stimuli. Active DNA demethylation is crucial for DC differentiation and function. Vitamin C, a known cofactor of ten-eleven translocation (TET) enzymes, drives active demethylation. Vitamin C has recently emerged as a promising adjuvant for several types of cancer; however, its effects on human immune cells are poorly understood. In this study, we investigate the epigenomic and transcriptomic reprogramming orchestrated by vitamin C in monocyte-derived DC differentiation and maturation. Vitamin C triggers extensive demethylation at NF-kappaB/p65 binding sites, together with concordant upregulation of antigen-presentation and immune response-related genes during DC maturation. p65 interacts with TET2 and mediates the aforementioned vitamin C-mediated changes, as demonstrated by pharmacological inhibition. Moreover, vitamin C increases TNFbeta production in DCs through NF-kappaB, in concordance with the upregulation of its coding gene and the demethylation of adjacent CpGs. Finally, vitamin C enhances DC's ability to stimulate the proliferation of autologous antigen-specific T cells. We propose that vitamin C could potentially improve monocyte-derived DC-based cell therapies. CI - (c) The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research. FAU - Morante-Palacios, Octavio AU - Morante-Palacios O AD - Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916, Badalona, Barcelona, Spain. AD - Germans Trias i Pujol Research Institute (IGTP), 08916, Badalona, Barcelona, Spain. FAU - Godoy-Tena, Gerard AU - Godoy-Tena G AD - Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916, Badalona, Barcelona, Spain. FAU - Calafell-Segura, Josep AU - Calafell-Segura J AD - Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916, Badalona, Barcelona, Spain. FAU - Ciudad, Laura AU - Ciudad L AD - Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916, Badalona, Barcelona, Spain. FAU - Martinez-Caceres, Eva M AU - Martinez-Caceres EM AD - Division of Immunology, Germans Trias i Pujol Hospital, LCMN, Germans Trias iPujol Research Institute (IGTP), 08916, Badalona, Barcelona, Spain. AD - Department of Cell Biology, Physiology, Immunology, Autonomous University of Barcelona, 08193, Bellaterra, Barcelona, Spain. FAU - Sardina, Jose Luis AU - Sardina JL AD - Epigenetic Control of Haematopoiesis Group, Josep Carreras Research Institute (IJC), 08916, Badalona, Barcelona, Spain. FAU - Ballestar, Esteban AU - Ballestar E AUID- ORCID: 0000-0002-1400-2440 AD - Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916, Badalona, Barcelona, Spain. AD - Germans Trias i Pujol Research Institute (IGTP), 08916, Badalona, Barcelona, Spain. AD - Epigenetics in Inflammatory and Metabolic Diseases Laboratory, Health Science Center (HSC), East China Normal University (ECNU), Shanghai 200241, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Nucleic Acids Res JT - Nucleic acids research JID - 0411011 RN - PQ6CK8PD0R (Ascorbic Acid) RN - 0 (NF-kappa B) RN - 0 (RELA protein, human) RN - EC 1.13.11.- (TET2 protein, human) SB - IM MH - Humans MH - *Ascorbic Acid/pharmacology MH - Cell Differentiation/genetics MH - *Dendritic Cells MH - *NF-kappa B/metabolism MH - T-Lymphocytes/metabolism MH - *Epigenesis, Genetic MH - Cellular Reprogramming PMC - PMC9638940 EDAT- 2022/10/29 06:00 MHDA- 2022/11/09 06:00 PMCR- 2022/10/28 CRDT- 2022/10/28 10:43 PHST- 2022/10/10 00:00 [accepted] PHST- 2022/09/23 00:00 [revised] PHST- 2022/06/22 00:00 [received] PHST- 2022/10/29 06:00 [pubmed] PHST- 2022/11/09 06:00 [medline] PHST- 2022/10/28 10:43 [entrez] PHST- 2022/10/28 00:00 [pmc-release] AID - 6777795 [pii] AID - gkac941 [pii] AID - 10.1093/nar/gkac941 [doi] PST - ppublish SO - Nucleic Acids Res. 2022 Oct 28;50(19):10981-10994. doi: 10.1093/nar/gkac941.